SPRY Therapeutics, Inc.
PrivateLast Round
Early Funding
Oct 9, 2024
Est. Valuation
$68.9M
Total Funding Raised
$25M
Company Overview
SPRY Therapeutics, Inc. is a health technology company that provides an AI-powered, end-to-end patient and practice management SaaS platform for physical rehabilitation clinics.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Vertical SaaS, Revenue Cycle, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPRY Therapeutics, Inc. Comparables
Compare SPRY Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prompt Health | 91% | |
| WebPT | 86% | |
| PtEverywhere | 83% |
SPRY Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 9, 2024 | ||||
| Series A | Jun 22, 2022 | ||||
| Seed | Dec 14, 2021 |
Key People
Founding team and executive leadership
SPRY Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AngelList | Seed |
| F-Prime Capital | Early Funding, Series A |
| Eight Roads Ventures | Early Funding, Series A |
| Flourish Ventures | Early Funding |
| FJ Labs | Seed |
| F-Prime Capital | Early Funding, Series A |
| Whiteboard Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Added BEST Physical Therapy as a new customer.
- Oct 7, 2025
Added Motion Physical Therapy & Rehab Inc. as a customer.
Recent news
Latest coverage and updates
- recognized_asJul 23, 2026
Spry Therapeutics Inc. recognized as #1 by Black Book Research in the Ambulatory EHR category for Physical & Occupational Therapy on Jul 1st '26.
SPRY Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SPRY Therapeutics, Inc.'s valuation, stock price, and market status.
Is SPRY Therapeutics, Inc. a public or private company?
SPRY Therapeutics, Inc. is a private company.
What is the current stock price of SPRY Therapeutics, Inc.?
SPRY Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks SPRY Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SPRY Therapeutics, Inc. worth (valuation)?
SPRY Therapeutics, Inc.'s valuation is estimated at $68.9M based on funding round data.
Can I buy SPRY Therapeutics, Inc. stock?
SPRY Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SPRY Therapeutics, Inc.'s last funding round?
SPRY Therapeutics, Inc.'s most recent funding round was Early Funding on October 9, 2024.
Who are the main investors in SPRY Therapeutics, Inc.?
Key investors in SPRY Therapeutics, Inc. include Eight Roads Ventures, Flourish Ventures, Together Fund.
Will SPRY Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for SPRY Therapeutics, Inc..
How can I track SPRY Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SPRY Therapeutics, Inc.'s shares on secondary markets.